Vincenzi, B., Bui, N., Dileo, P., Federman, N., Riedel, R. F., Van Tine, B. A., … Kasper, B. (2024). Efficacy of nirogacestat in participants with poor prognostic factors for desmoid tumors: Analyses from the randomized phase 3 DeFi study. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 42).

Vincenzi, Bruno, Nam Bui, Palma Dileo, Noah Federman, Richard F. Riedel, Brian Andrew Van Tine, Vincent Amoruccio, Allison Lim, Ana B. Oton, and Bernd Kasper. “Efficacy of nirogacestat in participants with poor prognostic factors for desmoid tumors: Analyses from the randomized phase 3 DeFi study.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 42, 2024.

Vincenzi B, Bui N, Dileo P, Federman N, Riedel RF, Van Tine BA, et al. Efficacy of nirogacestat in participants with poor prognostic factors for desmoid tumors: Analyses from the randomized phase 3 DeFi study. In: JOURNAL OF CLINICAL ONCOLOGY. 2024.

Vincenzi, Bruno, et al. “Efficacy of nirogacestat in participants with poor prognostic factors for desmoid tumors: Analyses from the randomized phase 3 DeFi study.” JOURNAL OF CLINICAL ONCOLOGY, vol. 42, no. 16, 2024.

Vincenzi B, Bui N, Dileo P, Federman N, Riedel RF, Van Tine BA, Amoruccio V, Lim A, Oton AB, Kasper B. Efficacy of nirogacestat in participants with poor prognostic factors for desmoid tumors: Analyses from the randomized phase 3 DeFi study. JOURNAL OF CLINICAL ONCOLOGY. 2024.